CagriSema vs Tirzepatide: Weight Loss Results in REDEFINE 4 Trial Paramesh Shamanna posted on the topic LinkedIn In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Retatrutide vs Tirzepatide vs Semaglutide comparison Voy CagriSema vs Tirzepatide: Amylin GLP 1 vs GIP GLP 1 for Maximum Weight Loss Which Is Better? PPW Peptide Protocol Wiki